Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2018
Number of items: 2.

2018

Awasthi, Rakesh, Mueller, Karen Thudium, Yanik, Gregory A., Tam, Constantine Si Lun, Rives, Susana, McGuirk, Joseph, Boyer, Michael W., Jager, Ulrich, Baruchel, Andre, Myers, Gary Douglas, Borchmann, Peter, Jaglowski, Samantha Mary, Stefanski, Heather E., Bishop, Michael Russell, Waldron, Edward K., Hamilton, Jason, Cota, Mariana, Bubuteishvili-Pacaud, Lida and Waller, Edmund K. (2018). Considerations for tisagenlecleucel dosing rationale. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mueller, Karen Thudium, Grupp, Stephan A., Maude, Shannon L., Levine, John E., Pulsipher, Michael, Boyer, Michael W., August, Keith Jason, Myers, Gary Douglas, Awasthi, Rakesh, Waldron, Edward K., Bubuteishvili-Pacaud, Lida, Taran, Tanya, Cota, Mariana, Tam, Constantine Si Lun, Jager, Ulrich, Foley, Ronan, Borchmann, Peter, Schuster, Stephen J., Waller, Edmund K. and Laetsch, Theodore Willis (2018). Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Sun Apr 18 03:40:53 2021 CEST.